Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice

Blood

Volumn 113, Issue 8, 2009, Pages 1841-1844

  Bair, Steven ^a   Spaulding, Emily ^a   Parkkinen, Jaakko ^a   Shulman, Howard M ^a,b   Lesnikov, Vladimir ^a   Beauchamp, Mary ^c   Canonne Hergaux, François ^d   Kowdley, Kris V ^b,c   Deeg, H Joachim ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN 1; HEPCIDIN; IRON; IRON REGULATORY FACTOR;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOCOMPATIBILITY; INTESTINE; INTESTINE INJURY; INTESTINE VILLUS; IRON ABSORPTION; IRON BALANCE; IRON BLOOD LEVEL; IRON INTAKE; IRON OVERLOAD; ISOGRAFT; LIVER; LIVER CELL; LIVER CELL DAMAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; T LYMPHOCYTE; UPREGULATION;

EID: 61849148183     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-178517     Document Type: Article

References (21)

1. Altes A, Remacha AF, Sarda P, et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant. 2004;34:505-509.
2. Strasser SI, Kowdley KV, Sale GE, McDonald GB. Iron overload in bone marrow transplant recipients. Bone Marrow Transplant. 1998;22:167-173.
3. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoi-etic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:506-510.
4. Gordon LI, Brown SG, Tallman MS, et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radic Biol Med. 1995;18:383-389.
5. Parkkinen J, Sahlstedt L, von Bonsdorff L, Salo H, Ebeling F, Ruutu T. Effect of repeated apo-transferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol. 2006;135:228-234.
6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation (review). Blood. 2003;102:783-788.
7. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219-230.
8. McDonald GB, Kearney DJ. Graft-versus-host disease. In: Weinstein WM, Hawkey CJ, Bosch J, eds. Clinical Gastroenterology and Hepatology. Philadelphia, PA: Elsevier Inc; 2005:837-843.
9. Shulman HM, McDonald GB. Hepatic complications of hematopoietic cell transplantation. In: Gershwin ME, Vierling JM, Manns MP, eds. Liver Immunology: Principles and Practice. Totowa, NJ: Humana Press Inc; 2007:409-421.
10. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45:340-346.
11. Lesnikov VA, Abbasi N, Lesnikova MP, et al. Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron. Apo-ptosis. 2006;11:79-87.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
13. Lesnikov VA, Lesnikova MP, Shulman HM, et al. Prevention of Fas-mediated hepatic failure by transferrin. Lab Invest. 2004;84:342-352.
14. Canonne-Hergaux F, DonovanA, Delaby C, Wang HJ, Gros P. Comparative studies of duodenal and macrophage ferroportin proteins. Am J Physiol Gastrointest Liver Physiol. 2006;290: G156-G163.
15. van Bekkum DW, de Vries MJ. Radiation Chimae-ras. London, United Kindom: Logos Press Limited; 1967.
16. Lesnikov V, Gorden N, Fausto N, et al. Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2. Apoptosis. 2008;13: 1005-1012.
17. Yada S, Takamura N, Inagaki-Ohara K, et al. The role of p53 and Fas in a model of acute murine graft-versus-host disease. J Immunol. 2005;174: 1291-1297.
18. Socie G, Mary JY, Lemann M, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood. 2004;103:50-57.
19. Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Br J Haematol. 2002;119:547-553.
20. Pierpaoli W, Dall'Ara A, Yi CX, Neri P, Santucci A, Choay J. Iron carrier proteins facilitate engraft-ment of allogeneic bone marrow and enduring hemopoietic chimerism in the lethally irradiated host. Cell Immunol. 1991;134:225-234.
21. Deeg HJ, Pierpaoli W, Arrighi S, et al. Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin? Transpl Immunol. 1996;4: 113-116.